New weight loss drug may burn fat without muscle loss seen in GLP-1 drugs

Key Points:

• Researchers at UC Berkeley have identified a new compound called TOFA that may help burn fat without the muscle loss commonly seen with weight-loss drugs like Ozempic, Wegovy, and Zepbound.
• Unlike GLP-1 medications that suppress appetite, TOFA boosts metabolism and blocks enzymes involved in fat and cholesterol production, allowing increased energy burn without reducing food intake.
• In mouse studies, TOFA-treated animals burned up to 18% more energy without eating less or exercising more, potentially offering a new approach to obesity and diabetes treatment.
• Muscle loss is a significant concern with GLP-1 drugs because it impairs blood sugar regulation and metabolism, with some patients losing up to 20% of lean muscle mass during rapid weight loss.
• Researchers suggest TOFA could be used alongside GLP-1 medications for enhanced weight loss, but emphasize that TOFA is still in early development and has not yet been tested in humans.